BTIG Logo

Cognoa to Participate in BTIG Digital Health Forum 

[Palo Alto, Calif. – November 16, 2022] – Cognoa, a leading pediatric behavioral health company, today announced that Sharief Taraman, MD, DABPN, DABPM, FAAP, Chief Executive Officer of Cognoa, will participate in the opening analyst-led fireside chat at the BTIG Digital Health Forum on Monday, November 21, 2022 at 7 a.m. ET / 4 a.m. PT. Cognoa management will be…

Sharief Taraman, MD, DABPN, DABPM, FAAP Chief Executive Officer

Cognoa Appoints Pediatric Neurologist and AI in Healthcare Pioneer Dr. Sharief Taraman as CEO to Spearhead the Next Stage of the Company’s Growth

Cognoa is on track for U.S. commercialization of Canvas Dx in 2023 as the first FDA authorized diagnostic device for early and equitable diagnosis of autism in young children [Palo Alto, Calif. – November 14, 2022] – Cognoa, a pediatric behavioral health company, today announced the appointment of Dr. Sharief Taraman as Chief Executive Officer. Dr. Taraman previously served as…

aap logo

Cognoa Announces Poster Presentations at the 2022 American Academy of Pediatrics (AAP) National Conference and Exhibition

[Palo Alto, Calif. – October 6, 2022] – Cognoa, a pediatric behavioral health company, today announced that the Company will be participating in the 2022 American Academy of Pediatrics (AAP) National Conference and Exhibition, taking place October 7 – 11, 2022, at the Anaheim Convention Center in Anaheim, California, and online.    The Company will present two scientific posters. Details…

Echo Autism Communties

ECHO Autism Communities Collaborate with Cognoa to Study Real-World Application of Canvas Dx 

[Palo Alto, Calif. – June 1, 2022] – Cognoa, a pediatric behavioral health company, is announcing the initiation of a real-world evidence study of its novel AI-based software as a medical device, Canvas Dx, in collaboration with the University of Missouri (MU) ECHO Autism Communities Research Team. ECHO Autism Communities is a telementoring program that increases participating clinicians’ expertise in…

NPJ Digital Medicine Logo

Cognoa Announces Nature Digital Medicine Publication of Pivotal Study Results Showing the Effectiveness of its Digital Diagnostic Device for Autism

Palo Alto, Calif, May 5, 2022 – Cognoa, a pediatric behavioral health company, today announced that npj Digital Medicine, a Nature Portfolio journal, has published data from its pivotal study of the company’s AI-based diagnosis aid for autism spectrum disorder (ASD), Canvas Dx™. Canvas Dx is the first and only FDA-authorized diagnostic device designed to support providers in the diagnosis…

Fierce 15 Logo

Cognoa Named One Of Fierce Medtech’s 2022 Fierce 15

Palo Alto, CA – March 7, 2022 – Cognoa, a leading pediatric behavioral health company, today announced that it has been named by Fierce Medtech as one of 2021’s Fierce 15 med tech companies, designating it as one of the most promising private med tech companies in the industry.  “With the first FDA-authorized AI-based diagnosis aid for autism, we are…

Cognoa logo.

Cognoa Receives FDA Marketing Authorization for First-of-its-kind Autism Diagnosis Aid

Cognoa’s AI-driven device is the first FDA-authorized diagnosis aid designed to help primary care physicians diagnose autism in young children with the goal of shortening time-to-diagnosis and enabling initiation of earlier interventions (Palo Alto, Calif. – June 2nd, 2021) – Cognoa, a pediatric behavioral health company developing diagnostic and therapeutic solutions for children living with behavioral health conditions, today announced…

photo of Eric Mosbrooker COO

Cognoa Appoints Industry Veteran Eric B. Mosbrooker as Chief Operations Officer

Mosbrooker will be leading the operational and commercial efforts of Cognoa’s digital behavioral health products (Palo Alto, Calif. – January 14, 2021) – Cognoa, the leading pediatric behavioral health company developing diagnostic and therapeutic solutions for children living with autism and other behavioral health conditions, today announced the appointment of Eric B. Mosbrooker as Chief Operations Officer. Mosbrooker will be…